论文部分内容阅读
用茶色素与诺衡治疗３９１例高血脂或伴有高纤维蛋白原的患者，随机分成两组，茶色素组１９６例，服茶色素胶囊０２５ｇ，每日３次；诺衡组１９５例，服诺衡胶囊０６ｇ，每日２次。疗程为１月，服药前、后测定血脂、纤维蛋白原。服茶色素１月后，血清胆固醇（Ｃｈ）、甘油三脂（ＴＧ）、低密度脂蛋白胆固醇（ＬＤＬ－Ｃ）、纤维蛋白原（Ｆｂｇ）分别下降２８％，６３６％，３４５％，５２９％，高密度脂蛋白胆固醇（ＨＤＬ－Ｃ）上升３７５％；总有效率为Ｃｈ９０３％，ＴＧ９６％，ＬＤＬ－Ｃ９２６％，ＨＤＬ－Ｃ８７７％，Ｆｂｇ９３８％。两药治疗高血脂症疗效差异无显著性（Ｐ＞００５）；降Ｆｂｇ的效果差异有高度显著性（ｔ＝３５０７，Ｐ＜００１）。副作用发生率茶色素为３１％，诺衡组２７８％，差异有高度显著性（ｔ＝８４３６，Ｐ＜０００１）。茶色素治疗高血脂、高纤维蛋白原血症有确切的疗效，无毒副作用。
391 patients with hyperlipidemia or hyper fibrinogen were treated with tea pigment and Noble, and were randomly divided into two groups: 196 for tea pigment group and 025g for tea pigment capsule for 3 times a day; 195 for Nobleton group , Nuobu capsule 0 6g, 2 times a day. The course of treatment was January, and the blood lipid and fibrinogen were measured before and after taking the medicine. Serum cholesterol (Ch), triglyceride (TG), low density lipoprotein cholesterol (LDL-C) and fibrinogen (Fbg) decreased by 28%, 636%, 345 %, 52.9%, HDL-C increased 37.5%; the total effective rate was Ch90.3%, TG96%, LDL-C92.6%, HDL-C87.7%, Fbg93 8%. There was no significant difference between the two groups in the treatment of hyperlipidemia (P> 005). The effect of lowering Fbg was highly significant (t = 3507, P <001). The incidence of side effects of tea pigment was 3 1%, Nuoban 27 8%, the difference was highly significant (t = 8 436, P <0 001). Tea pigment treatment of hyperlipidemia, hyperfibrinogenemia have the exact effect, non-toxic side effects.